Literature DB >> 7277649

Fatal vidarabine toxicity in a patient with normal renal function.

L Van Etta, J Brown, A Mastri, T Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7277649     DOI： 10.1001/jama.246.15.1703

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Therapy of viral infections.

Authors:  M H Grieco
Journal:  Bull N Y Acad Med       Date:  1982-11

2.  Neurotoxic effects during vidarabine therapy for herpes zoster.

Authors:  D R Burdge; A W Chow; S L Sacks
Journal:  Can Med Assoc J       Date:  1985-02-15       Impact factor: 8.262

3.  Inhibition of B virus (Macacine herpesvirus 1) by conventional and experimental antiviral compounds.

Authors:  P W Krug; R F Schinazi; J K Hilliard
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

4.  Vidarabine-associated encephalopathy and myoclonus.

Authors:  R W Vilter
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.

Authors:  J L Abbruzzese; S Schmidt; M N Raber; J K Levy; A M Castellanos; S S Legha; I H Krakoff
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.